Advertisement

J&J Profit Falls; Forecast Boosted

Updated ET

Johnson & Johnson's first-quarter earnings declined 23% from a year-earlier period that was boosted by a litigation gain, while a series of product recalls continued to hamper sales growth. George Stahl, Paul Vigna and Kristina Peterson discuss.

The health-care giant boosted its full-year earnings forecast, citing currency trends and improvements in J&J's underlying business.

J&J had said in recent quarters that overall health-care spending was slowing due to the sluggish economy, but on a conference call with analysts, Chief Financial Officer Dominic Caruso said it is "seeing some sequential improvements."

Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

What's News

Top stories chosen by WSJ editors

Most Popular News

Recommended for You

Top Stories

Most Popular

Recommended for You